Rajan Giri

Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents

Rajan Giri, Hardik M. Thaker, Tony Giordano et al. · European Journal of Medicinal Chemistry · 2008 · 164 citations · Full text

Medicinal Chemistry, -3-Aryl-3h-quinazoline-4-one Derivatives, Anti-inflammatory +11

Synthesis and cancer cell cytotoxicity of substituted xanthenes

Rajan Giri, John R. Goodell, Chenguo Xing et al. · Bioorganic & Medicinal Chemistry · 2010 · 97 citations

Heterocyclic, Anti-cancer Agent, Heterocycle Chemistry +2

Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-кB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents

Rajan Giri, Hardik M. Thaker, Tony Giordano et al. · Bioorganic & Medicinal Chemistry · 2010 · 43 citations · Full text

Anti-cancer Agents, Transcription Factors Nf-кb, Medicine +8

Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma

Alexandra Foster, Shubhanchi Nigam, David S. Tatum et al. · EBioMedicine · 2021 · 42 citations · Full text

Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-κB, AP-1 mediated transcription and eIF-4E mediated translational activation: Inhibitors of multi-pathways involve in cancer

Rajan Giri, Hardik M. Thaker, Tony Giordano et al. · European Journal of Medicinal Chemistry · 2010 · 32 citations · Full text

Molecular Pharmacology, Medicine, Translational Activation +8